Alimera Sciences Inc (NASDAQ:ALIM)

Data as of Jan 30
 -0.08 / -1.45%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Alimera Sciences, Inc. is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. It focuses on diseases affecting the back of the eye, or retina. Its primary product, ILUVIEN, for the treatment of vision impairment associated with chronic diabetic macular edema considered insufficiently responsive to available therapies. Alimera Sciences was founded on June 4, 2003 by C. Daniel Myers and David R. Holland and is headquartered in Alpharetta, GA.

Contact Information

Alimera Sciences, Inc.
6120 Windward Parkway
Alpharetta Georgia 30005
P:(678) 990-5740
Investor Relations:



Mutual fund holders6.80%
Individual stakeholders53.85%
Other institutional31.31%

Top Executives

Charles Daniel MyersPresident, Chief Executive Officer & Director
Richard S. EiswirthSecretary, Chief Operating & Financial Officer
Kenneth GreenChief Scientific Officer & Senior Vice President
Susan H. CaballaSenior VP-Regulatory & Technical Affairs
David R. HollandSenior Vice President-Sales & Marketing

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.